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Abstract
In statistical bioinformatics research, different optimization mechanisms potentially lead to “over-optimism” in
published papers. The present empirical study illustrates these mechanisms through a concrete example from
an active research field. The investigated sources of over-optimism include the optimization of the data sets, of
the settings, of the competing methods and, most importantly, of the method’s characteristics.
We consider a “promising” new classification algorithm that turns out to yield disappointing results in terms
of error rate, namely linear discriminant analysis incorporating prior knowledge on gene functional groups
through an appropriate shrinkage of the within-group covariance matrix. We quantitatively demonstrate that
this disappointing method can artificially seem superior to existing approaches if we “fish for significance”. We
conclude that, if the improvement of a quantitative criterion such as the error rate is the main contribution of a
paper, the superiority of new algorithms should be validated using “fresh” validation data sets.
The R codes and preprocessed versions of the data sets as well as additional files can be downloaded from
http://www.ibe.med.uni-muenchen.de/organisation/mitarbeiter/020
−
professuren/boulesteix/overoptimism/,
such that the study is completely reproducible.
Keywords: Validation, fishing for significance, meta-methodology, KEGG, discriminant analysis, shrinkage
covariance estimator
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1 Introduction
In statistical bioinformatics research, the reported results on the performance of new algorithms
are known to be over-optimistic, as recently discussed in a letter to the editors of Bioinformatics
(Boulesteix, 2010). The current paper aims at illustrating the different mechanisms leading to over-
optimism through a concrete example from an active methodological research field.
The first and perhaps most obvious reason for over-optimism is that researchers sometimes ran-
domly search for a specific data set such that their new method works better than existing approaches.
While a method cannot reasonably be expected to yield “universally better” results in all data sets,
it would be wrong to report only favorable data sets without mentioning and/or discussing the other
results. This strategy induces an optimistic bias. This aspect of over-optimism is quantitatively in-
vestigated in the study by Yousefi et al. (2010) and termed as “optimization of the data set” in this
paper.
The second source of over-optimism, which is related to the optimal choice of the data set men-
tioned above, is the optimal choice of a particular setting in which the superiority of the new algorithm
is more pronounced. For example, researchers could report the results obtained after a particular fea-
ture filtering after they notice that this setting favors the new algorithm compared to existing bench-
mark approaches. This mechanism is termed as “optimization of the settings” in this paper.
The third source of over-optimism is related to the choice of the existing benchmark methods ap-
plied for comparison purposes. Researchers may consciously or subconsciously choose suboptimal
existing methods and exclude the best competing methods from the comparison for any reason, e.g.
because running the software demands very particular knowledge, because previous authors excluded
these methods as well, because the methods induce high computational expense or because they be-
long to a completely different family of approaches and thus do not fit in the considered framework.
Then the new algorithm artificially seems better than competing approaches and over-optimistic re-
sults on the superiority of the new algorithm are reported – because the best competing approaches
are disregarded. This mechanism is termed as “optimization of the competing methods” in this paper.
Finally, researchers often tend to optimize their new algorithms to the data sets they consider dur-
ing the development phase (Boulesteix, 2010). This mechanism essentially affects all research fields
related to data analysis such as statistics, machine learning, or bioinformatics. Indeed, the trial-and-
error process constitutes an important component of data analysis research. As most inventive ideas
have to be improved sequentially before reaching an acceptable maturity, the development of a new
method is per se an unpredictable search process. The problem is that, as stated by the Bioinformat-
ics editorial team (Rocke et al., 2009), this search process leads to an artificial optimization of the
method’s characteristics to the considered data sets. Hence, the superiority of the novel method over
an existing method (as measured, e.g. through the difference between the cross-validation error rates)
is sometimes considerably overestimated. In a concrete medical prediction study, fitting a prediction
model and estimating its error rate using the same training data set yields a downwardly biased er-
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ror estimate commonly termed as apparent error. In the same spirit, computing cross-validation error
rates with different classifiers and systematically selecting the classifier variant with the smallest error
rate yields a substantial optimization bias (Boulesteix and Strobl, 2009). Similarly, developing a new
algorithm (i.e. selecting one of many variants) and evaluating it by comparison to existing methods
using the same data set may lead to optimistically biased results in the sense that the new algorithm’s
characteristics overfit the used data set. This source of over-optimism is termed as “optimization of
the method’s characteristics” in this paper.
The four mechanisms discussed above may lead to over-optimistic conclusions regarding the
superiority of the new method compared to existing methods. The importance of validation with
independent data has recently gained much attention in biomedical literature. For instance, we refer
to the empirical study by Daumer et al. (2008) which points out the usefulness of a pre-publication
validation strategy based on data-splitting. To our knowledge, no such study was performed in the
context of methodological bioinformatics research and this issue has long been underconsidered in
the literature.
The present paper aims at filling this gap. It reviews and illustrates the problem of validation and
false research findings through a concrete example within a hot research field: the incorporation of
prior biological knowledge on gene functional groups into high-dimensional microarray-based clas-
sification. The “promising idea” we originally pursued was to modify the well-established shrinkage
covariance estimator by Schäfer and Strimmer (2005) by incorporating prior knowledge on gene
functional groups with the aim to improve the performance of linear discriminant analysis. This new
approach can be seen as a combination of a simple and well-established statistical method, namely
the shrinkage estimator of the covariance, with a popular concept (the incorporation of prior biolog-
ical knowledge into classification) that has attracted a lot of attention in the last few years (Tai and
Pan, 2007a,b; Rapaport et al., 2007; Li and Li, 2008; Guillemot et al., 2008; Binder and Schumacher,
2009; Jacob et al., 2009; Yousef et al., 2009; Slawski et al., 2010; Hall and Xue, 2010). For these
reasons, we considered this new approach as promising. However, it turned out that this interesting
method does not yield any improvement in terms of prediction error rate.
Based on this concrete example, we show that over-optimistic results can be obtained through
the four mechanisms discussed above. We demonstrate quantitatively that optimization of the data
set, optimization of the settings, optimization of the competing methods and, most importantly, op-
timization of the method’s characteristics can lead to substantially biased results and over-optimistic
conclusions on the superiority of the new method. Note that this study is deliberately of empirical
nature. We neither model the different sources of over-optimism theoretically nor do we derive ana-
lytical expressions of the resulting bias for simplified situations, because we feel it would not reflect
the complexity of the addressed mechanisms. Instead, we stick to concrete observations to illustrate
what consciously or subconsciously happens in virtually all methodological projects – possibly in-
cluding our own projects. We feel that a quantitative demonstration of the optimistic bias affecting
methodological research may perhaps increase awareness on such problems and give researchers food
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for thoughts.
The remainder of this paper is organized as follows. The promising idea is briefly sketched in Sec-
tion 2.1 to make our considerations on validation more understandable. The design of the analysis is
described in Section 2.2, while Section 3 presents the results of the new and existing methods on four
real-life data sets and the different interpretations depending on whether one fishes for significance or
not. Further potential sources of biases and possible explanations for the disappointing results of the
promising idea are discussed in Section 4.
2 Methods
2.1 A “promising idea”
This section briefly sketches the promising idea we originally pursued to make our considerations
and results on over-optimism more understandable. Note, however, that this promising idea is not
the scientific contribution of our paper, but rather a concrete example serving as an illustration for
the four investigated optimization mechanisms. Readers who are not interested in the methodological
details of the promising idea but rather in the quantitative evaluation of the optimization mechanisms
can skip this section.
2.1.1 Discriminant analysis and its regularized variants
Let us consider a high-dimensional data set with continuous predictors such as microarray gene ex-
pression data. The latter are often used to predict a categorical response variable of interest, e.g. the
disease status or the long-term disease outcome.
Discriminant analysis (DA) is a widely used classification method. DA is based on the assumption
that the random vector x of predictors follows a multivariate normal distribution x|(Y = r) ∼
N (µr,Σr) within each class r (for r = 1, . . . , c). A new observation xnew is then assigned to the
class with maximal posterior probability. This decision rule can be formulated in terms of a simple
decision function which is linear in xnew if the covariance matrices Σ1, . . . ,Σc are assumed to be
equal, yielding the so-called Linear Discriminant Analysis (LDA). Most importantly, the decision
function involves the inverse Σ−1 of the covariance matrix Σ. In standard n > p settings, Σ−1 is
simply estimated through the inverse S˜−1 of the pooled estimator S˜ of the within-covariance matrix,
which is itself defined as a weighted sum of the unbiased estimators of the within-class covariance
matrices. More technical details on classical LDA are given in the Additional File 1 available from
the companion website.
In the high-dimensional setting considered here the pooled covariance estimator S˜ mentioned
above is singular, thus not invertible. The concept of Regularized Linear Discriminant Analysis
(RLDA) aims at solving the singularity problem by modifying S˜ such that the resulting estimator
becomes invertible. See for instance the seminal paper on Regularized (Fisher’s) Discriminant Anal-
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ysis by Friedman (1989) and the work by Guo et al. (2007) on Shrunken Centroids Regularized
Discriminant Analysis (SCRDA) which are both based on the widely employed shrinkage principle
(Stein, 1955; Efron and Morris, 1977).
2.1.2 Regularized LDA with KEGG
An increasingly popular approach is to regularize the within-class covariance by incorporating ex-
ternal biological knowledge from databases like the Kyoto Encyclopedia of Genes and Genomes
(KEGG) (Kanehisa and Goto, 2000). The underlying motivation of this approach is to improve both
the prediction accuracy and the results’ interpretability.
KEGG is a freely available database of biological systems consisting of multiple sub-databases.
KEGG PATHWAY as one of these sub-databases contains a collection of pathway maps representing
recent knowledge on molecular interaction and reaction networks for metabolism, various cellular
processes and human diseases (Kanehisa and Goto, 2000). More precisely, pathways are represented
as graphs in which the edges stand for the chemical reactions or relations and the vertices stand for
the genes involved.
In the context of microarray-based classification, Tai and Pan (2007a) assume that a KEGG path-
way forms a gene functional group. They postulate that genes from the same functional group tend
to be more correlated than genes from different functional groups, and that information from KEGG
can thus be used to improve the modelling of between-genes correlation in the context of classifica-
tion. Starting from these attractive ideas, we propose an alternative simple approach to incorporate
prior knowledge from KEGG into the estimation of the correlation, with applications to LDA. The
promising idea can be seen as a further variant of RLDA incorporating biological knowledge on gene
functional groups extracted from KEGG via a modified shrinkage estimator of the covariance matrix,
as outlined in Sections 2.1.3 and 2.1.4.
2.1.3 The shrinkage estimator Σ̂SHIP incorporating prior knowledge
To address the methodological challenges arising from the n≪ p data situation (the pooled estimate
S˜ of the covariance matrix is not invertible), we now propose a covariance estimation procedure we
refer to as SHIP standing for SHrinking and Incorporating Prior knowledge. The resulting covariance
estimator Σ̂SHIP is based on the shrinkage estimator introduced by Ledoit and Wolf (2003, 2004) and
applied by Schäfer and Strimmer (2005) in the context of high-dimensional genomic data. Addition-
ally, the new estimator incorporates prior biological knowledge on gene functional groups extracted
from the KEGG database.
In a few words, the shrinkage estimator originally proposed by Ledoit and Wolf is the asymp-
totically optimal convex linear combination Σ̂∗ = λT + (1 − λ)S, where λ ∈ [0, 1] denotes the
analytically determined optimal shrinkage intensity, T stands for a structured covariance target, and
S is the unstructured standard unbiased empirical covariance matrix. The resulting “shrinkage estima-
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tor” of the covariance matrix Σ is then invertible (provided T is chosen adequately) and stabilized.
The optimal shrinkage intensity λ is determined with respect to a quadratic loss function which is
common and intuitive in statistical decision theory, resulting in a simple analytical formula (Schäfer
and Strimmer, 2005). See Additional File 1 for more details on the computation of λ.
The covariance target T plays an essential role in the computation of the shrinkage estimator by
Ledoit and Wolf. Its choice, however, turns out to be very complex. On the one hand, T is required
to be positive definite and to involve only a small number of free parameters. On the other hand, it
should reflect important characteristics of the covariance structure between the variables (genes). An
overview of commonly used covariance targets A to F is given in Schäfer and Strimmer (2005). In
this paper, we consider target D and target F with constant correlation as reference methods (see Table
1, left and middle).
In order to incorporate information from KEGG PATHWAY, we propose a modified version
of target F where pairs of connected genes (i.e. genes from the same gene functional group) have
non-zero common correlation r¯. This correlation is simply given as the mean correlation of all pairs
of connected genes. In case a gene does not occur in any gene functional group, we assume this
gene forming its own group with group size one as in Tai and Pan (2007a). The resulting target
G is displayed in Table 1 and yields the novel estimator Σ̂SHIP = λT + (1 − λ)S, where T is
defined according to target G and the optimal shrinkage intensity λ can be computed analytically
(see Additional File 1). The shrinkage covariance estimator Σ̂SHIP is implemented in the R package
‘SHIP’ which is publicly available from the companion website.
Target D Target F Target G
tij =
{
sii if i = j
0 if i 6= j tij =
{
sii if i = j
r¯
√
siisjj if i 6= j
tij =


sii if i = j
r¯
√
siisjj if i 6= j, i ∼ j
0 otherwise
Table 1: Overview of targets D (diagonal, unequal variance), F (constant correlation) and G (where r¯
is the average of sample correlations). The notation i ∼ j means that genes i and j are connected, i.e.
genes i and j are in the same gene functional group. The term sij denotes the entry of the unbiased
covariance matrix in row i, column j.
2.1.4 Linear discriminant analysis using Σ̂SHIP
The resulting estimator Σ̂SHIP of the covariance matrix can then simply be used in the context of
LDA. In a nutshell, we compute the shrinkage estimators Σ̂
(r)
SHIP separately for each class r = 1, ..., c
and subsequently pool these within-class shrinkage estimators according to the standard procedure
known from LDA. See Additional File 1 for more details. Note that the resulting pooled estimator
is not necessarily positive definite, because the target is not always positive definite. However, it
is typically much better conditioned than S˜. To cope with this problem, we simply compute the
well-known Moore-Penrose pseudoinverse (Penrose, 1955).
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Our initial conjecture was that this variant of RLDA borrowing prior knowledge from KEGGmay
lead to an improvement of prediction accuracy. This conjecture is intentionally formulated rather
imprecisely. Of course, one may ask for a more concrete explanation of the term “improvement”.
This is indeed an important question we address in Section 3.
2.2 Design of the study
Since our quantitative study on the four optimization mechanisms is actually the real contribution of
our paper, the design of the study is presented as a part of the Methods section, following the four
optimization mechanisms outlined in the introduction.
2.2.1 Data sets
In this study, we successively consider four publicly available microarray data sets to illustrate the
potential optimization of the data set and demonstrate the importance of validation on different data
sets. Golub’s leukemia data set (n = 72, p = 7129) is part of the R package ‘golubEsets’ (Golub,
2010), while the CLL data set (n = 22, p = 12625) is available from the package ‘CLL’ (Whalen,
2010). The prostate data set by Singh et al. (2002) (n = 102, p = 12625) and the breast cancer data
set by Wang et al. (2005) (n = 286, p = 22283) are available from GEO. We normalized them using
the GCRMA method. The resulting data matrices are available from the companion website. All data
sets include a binary outcome variable which has to be predicted based on gene expression data. A
brief overview of the data sets is given in Additional File 1.
2.2.2 Settings
Prediction accuracy is estimated using the well-established 10 × five-fold cross-validation evaluation
scheme. Five-fold cross-validation is repeated 10 times in order to achieve more stable results (Braga-
Neto and Dougherty, 2004; Boulesteix et al., 2008). We focus on the average misclassification rate
as a measure of prediction accuracy, i.e. the average test error obtained over all 10× 5 = 50 test sets.
In order to limit the computational effort and to reduce the influence of noise we do not employ
all available genes of a data set, but perform variable selection (for each learning set successively, as
commonly recommended). We use three variable selection criteria: the standard t-test, the Limma
procedure by Smyth (2004) and the standard rank-based Wilcoxon test, each with four different num-
bers of selected genes (p∗ = 100, 200, 500, 1000). Hence, we obtain 3 × 4 = 12 combinations of
selection procedures and numbers of selected genes.
2.2.3 Competing methods
For comparison purposes, we furthermore apply the Diagonal Linear Discriminant Analysis (DLDA),
the Nearest Shrunken Centroids method (NSC) by Tibshirani et al. (2002) that is also called Prediction
Analysis with Microarrays (PAM), and Support Vector Machines (SVM) as competing approaches.
7
We perform variable selection for DLDA with p∗ = 100, 200, 500, 1000 and three selection methods
successively, Following common practice, we skip the variable selection for NSC and SVM where
the influence of irrelevant genes is reduced automatically. Tuning parameters for NSC (shrinkage
parameter) and SVM (cost) are optimized via internal three-fold cross-validation.
2.2.4 Method’s characteristics
When developing a new algorithm, researchers often adapt their method sequentially depending on
their experiences with example data sets and preliminary results. Many variants that are tried out at
this stage finally turn out to yield bad results or fail for any other reason. In contrast to the aspects
of the analysis design discussed above, this aspect often remains unmentioned when writing a paper,
except perhaps a few remarks in the discussion. However, the variants that are tried out during the
development of the new algorithms are in a broad sense part of the design of the analysis. Indeed, they
are often assessed using the same procedures as the final new algorithm that is eventually published.
When assessing the promising idea described in Section 2.1, we also thought of possible variants
of the proposed RLDA incorporating prior knowledge. In contrast to standard practice, we publicly
mention all these variants in the present paper and demonstrate what happens when one systematically
tries to optimize the new algorithm with regard to its characteristics.
Henceforth, the promising idea outlined in Section 2.1 is referred to as rlda.TG unless otherwise
emphasized. More precisely, the term rlda.TG specifies the regularized linear discriminant analysis
with the shrinkage estimators of the within-class covariance matrices being based on the knowledge-
based covariance target G as introduced in Section 2.1.3. During the development phase, we succes-
sively considered the ten following variants of rlda.TG termed as rlda.TG(1), . . . , rlda.TG(10). These
ten variants can be divided into two groups. The first group comprises rlda.TG(1) to rlda.TG(7) which
differ in the assignment of ambiguous genes (genes that are in no functional group or genes that are
in at least two different functional groups). While rlda.TG(1) excludes genes that are not in any gene
functional group (about 50 % in each data set) from the analysis, rlda.TG(2) eliminates genes occur-
ing in multiple gene functional groups. Both rlda.TG(3) and rlda.TG(4) proceed similarly to Tai and
Pan (2007a): if a gene occurs in multiple gene functional groups, the gene is kept in the gene func-
tional group with the smallest (largest) number of genes and ignored in the other ones. In case the
smallest (largest) gene functional group is not unique, one of these is chosen by chance. The meth-
ods rlda.TG(5) to rlda.TG(7) are obtained by combining rlda.TG(1) with rlda.TG(2), rlda.TG(3) and
rlda.TG(4). The second group comprises rlda.TG(8), rlda.TG(9) and rlda.TG(10) which are based on a
re-definition of the covariance target G. Variant rlda.TG(8) involves two parameters for the correlation
(a positive and a negative one) instead of the single parameter r¯, in order to account for negatively
correlated genes within the same pathway. The variant rlda.TG(9) completely ignores negative cor-
relations and computes the mean correlation using the positive ones. Finally, rlda.TG(10) tests the
correlations (with a level of 0.05) and sets the non-significant correlations to zero before the mean
correlation is computed.
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3 Results
3.1 General approach
This section presents different interpretations of the results of the new methods rlda.TG,
rlda.TG(1), . . . ,rlda.TG(10) and existing methods on four real-life data sets. While Section 3.2
presents the performance of the new algorithm(s) from an over-optimistic point of view (i.e. after
fishing for significance), Section 3.3 follows a less biased approach based on validation with indepen-
dent data sets.
The four optimization mechanisms are introduced sequentially and independently of each other
for clarity’s sake in Section 1. However, they are in fact tightly embedded in practice, thus making a
perfectly realistic study very difficult. In Section 3.2, we consider a simplified optimization process
mimicking one of many possible optimization scenarii for illustration purposes. We are aware of the
many other potential schemes, but an exhaustive study would go beyond this paper’s scope. We feel
that the chosen example reflects the influence of the four mechanisms reasonably well. In addition to
the results provided in this section, a more extensive report of the results is given in Additional File 2
available from the companion website.
In this study, all four data sets are first analysed independently of each other in Section 3.2 to
mimick what would happen if researchers did not try to validate their results on different data sets. It
is then shown in Section 3.3 that a proper validation strategy, in which researchers do not use the same
data sets to develop and to evaluate their new algorithm, leads to much less favorable results. The
whole analysis is completely reproducible using the R codes available from the companion website.
3.2 An (over-)optimistic view
3.2.1 Optimization of the settings
We first consider the new promising method rlda.TG while ignoring its variants
rlda.TG(1),. . . ,rlda.TG(10). The four data sets are analysed completely independently of each
other. For a given data set, someone “fishing for significance” may look for the variable selection
scheme and number p∗ of selected variables yielding the lowest error rate. In this spirit, Table 2
gives the classification error rates obtained with the 3× 4 combinations of variable selection scheme
and number p∗ of selected variables in each of the four investigated data sets. The bold numbers
indicate the minimal error rate for each data set. The standard errors of the error rates over the
cross-validation iterations range from 0.005 to 0.024 for the Golub data, from 0.022 to 0.031 for
the CLL data, from 0.009 to 0.012 for the Wang data, and from 0.008 to 0.021 for the Singh data.
Obviously, the classification error rates strongly depend on the variable selection settings. Moreover,
there is no universally better setting performing best for all data sets, although settings with small p∗
tend to yield smaller error rates in general.
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Selection procedure p∗ Golub CLL Wang Singh
t-test 100 0.029 0.234 0.382 0.081
200 0.029 0.269 0.375 0.133
500 0.032 0.220 0.383 0.166
1000 0.049 0.222 0.380 0.211
Limma 100 0.031 0.237 0.383 0.081
200 0.028 0.274 0.375 0.125
500 0.039 0.233 0.384 0.182
1000 0.060 0.225 0.376 0.224
Wilcoxon test 100 0.090 0.192 0.384 0.135
200 0.170 0.159 0.379 0.178
500 0.168 0.185 0.409 0.158
1000 0.124 0.221 0.402 0.197
Table 2: Overview of the CV errors obtained for rlda.TG where p∗ denotes the number of selected
genes. The bold values indicate the minimum values.
A researcher who “fishes for significance” would select the setting yielding the minimal error
rate for the data set (s)he considers, thus inducing an optimistic bias through “optimization of the
settings”.
3.2.2 Optimization of the method’s characteristics
Moreover, (s)he would certainly try to further improve the new algorithm’s performance by consid-
ering the additional variants rlda.TG(1), . . . , rlda.TG(10). Figure 1 displays the CV error rates of
rlda.TG and its variants in the selected setting(s) for each data set. Especially for the CLL and the
Wang data set, it can be clearly seen that some of the variants decrease the error rate substantially
compared to rlda.TG. All in all, we achieve the error rates 0.025 for the Golub data (with rlda.TG(5)),
0.129 for the CLL data (with rlda.TG(5)), 0.342 for the Wang data (with rlda.TG(6)), and 0.078 for
the Singh data (with rlda.TG(8)). This represents an improvement compared to the bold optimal
error rates from Table 2, illustrating the mechanism denoted as “optimization of the method’s
characteristics”.
3.2.3 Optimization of the competing approaches
Another mechanism of the optimization process is the choice of the competing approaches that are
compared to the new algorithm. For each of the four data sets, Table 3 shows the difference between
the error rate of the optimal method in the optimal setting and the error rate of rlda.TD (shrink-
age covariance with the diagonal target D), rlda.TF (shrinkage covariance with target F), and DLDA
(classical diagonal linear discriminant analysis). These competing approaches are applied after vari-
able selection following the optimal setting identified from Table 2. Further, results are shown for
two good standard methods without preliminary variable selection: the Nearest Shrunken Centroids
method (NSC) and the Support Vector Machines (SVM). Obviously, these competing approaches
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Figure 1: Overview of the CV error rates of the different variants of rlda.TG, obtained for all data
sets within the corresponding optimal settings sopt. The dashed line indicates the value obtained for
rlda.TG within the data-specific sopt. Note that for both the Wang and the Singh data the optimal
setting is not unique. The considered settings are: sopt = (200, Limma) for the Golub data, sopt = (200,
Wilcoxon test) for the CLL data, sopt
1 = (200, t-test) (left bar) and sopt
2 = (200, Limma) (right bar) for
the Wang data, and sopt
1 = (100, t-test) (left bar) and sopt
2 = (100, Limma) (right bar) for the Singh
data.
perform very differently. Hence, the new algorithm’s performance appears more or less impressive
depending on the competing methods shown in the comparison study.
A possible (critical) strategy could be to select the competing approaches depending on the
tested “research hypothesis”. If the hypothesis is that the new algorithm generally improves the
performance of state-of-the-art approaches, we would consider as many approaches as possible.
If the hypothesis is that it performs better than other LDA approaches, we would consider all
LDA-based competitors. If the hypothesis is that the incorporation of correlations is useful, we
would consider rlda.TD. If the hypothesis is that the incorporation of correlations becomes better
through KEGG-pathways, we would consider rlda.TF. This strategy may seem good at first view, but
yields some problems. First, the tested hypothesis should not be chosen a posteriori by the researcher
based on the results. Indeed, it can be seen from Table 3 that this also yields a kind of optimization.
Second, it may also lead to spurious results. For example, one may conclude from the negative
differences D(Mopt,rlda.TF) that KEGG is useful in this context. Another more realistic explanation
is that rlda.TG is better than rlda.TF because the estimated correlation matrix is sparser – and not
because of the KEGG pathways.
3.2.4 Optimization of the data set
Some researchers may also “optimize the data set” and choose to show only the results that are more
favorable to their method. For an extensive study on this problem including theoretical considerations,
see Yousefi et al. (2010). It can be clearly seen from Table 3 that the results on the CLL data are much
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Mopt D(Mopt,rlda.TD) D(Mopt,rlda.TF) D(Mopt,DLDA) D(Mopt,NSC) D(Mopt,SVM)
Golub rlda.TG(5) - 0.003 - 0.003 - 0.010 0.004 - 0.029
CLL rlda.TG(5) - 0.017 - 0.083 - 0.055 - 0.204 - 0.269
Wang rlda.TG(6) - 0.026 - 0.026 - 0.033 - 0.034 0.001
Singh rlda.TG(8) - 0.008 - 0.003 - 0.048 - 0.052 - 0.022
Table 3: Overview of the differences D between the error rates of the data-specific optimal variant
Mopt of rlda.TG and the methods rlda.TD, rlda.TF, DLDA, NSC and SVM within the data-specific
optimal setting sopt.
more favorable to our newmethod than the other three data sets. This is probably due to the very small
size (n = 22) implying a high variability and thus stronger optimization effects. The optimization of
the data set and the optimization of the settings may thus be tightly connected.
3.3 On the usefulness of validation with fresh data
Until now, the four data sets were analysed independently of each other. For each data set, we obtained
an optimal variant combined with an optimal setting, that seemingly performed better than existing
approaches, see Table 3. As previously discussed, these figures are the result of different optimization
processes. One of them – the optimization of the method’s characteristics – is an inherent component
of biostatistics/bioinformatics research and cannot be avoided. Up to a point, the optimization of the
settings can also be considered as inherent to data analysis research: for example, nobody expects
researchers to focus on settings in which all methods turn out to perform equally bad. So how should
we evaluate new methods and report their performance?
In this section, we show the importance of a proper validation using data sets that were not used for
the algorithm’s development. Table 4 shows the cross-validation error rates of the four combinations
of optimal settings and optimal variant when applied on the four data sets. Whereas the error rates
in the diagonal are the optimal error rates already mentioned in the previous section, the error rates
outside the diagonal can be seen as “validation error rates” computed on independent fresh data sets.
They are obviously much higher than the optimal error rates, illustrating the consequences of the
optimization processes.
In the same vein, Figure 2 displays the number of variable selection settings (out of 3× 4 = 12)
in which each of the variants rlda.TG,rlda.TG(1), . . . ,rlda.TG(10) yields the lowest error rate, for each
data set separately. It can be seen that the “optimal variant” strongly depends on the data set (because
the four rows are very different) and on the setting (because we have many intermediate values like
2,3,4,5 < 12). There is no clear winner, but readers may have the impression that there is a clear
winner if they do not see all the results (i.e. not all data sets or/and not all settings).
In conclusion, validation using fresh independent data that were not used in the development
phase would have avoided over-optimistic conclusions on the new algorithm’s superiority. This kind
of validation automatically corrects the bias induced by the optimization of the settings and the
optimization of the method’s characteristics.
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Mopt sopt CVEMopt Golub CVEMopt CLL CVEMopt Wang CVEMopt Singh
Golub rlda.TG(5) sopt = (200, Limma) 0.025 0.180 0.345 0.152
CLL rlda.TG(5) sopt = (200, Wilcoxon test) 0.079 0.129 0.363 0.141
Wang rlda.TG(6) sopt = (200, t-test) 0.029 0.221 0.342 0.115
Singh rlda.TG(8) sopt = (100, Limma) 0.033 0.274 0.384 0.078
Table 4: Performance of the optimal variants Mopt of rlda.TG within the optimal settings sopt selected
in each of the four data sets. The figures outside the diagonal can be understood as “validation error
rates”.
Figure 2: Frequency distribution of the variants of rlda.TG yielding the lowest error rates. The fre-
quencies f are summed over three variable selection methods (t-test, Limma, Wilcoxon test) and four
numbers of genes (100, 200, 500, 1000). Note that the “best” variant is not necessarily unique, i.e.
the sum of the row-specific frequencies can be > 12.
4 Discussion
As illustrated in Section 3 based on the example of regularized LDA, the four investigated sources
of over-optimism may yield substantially over-optimistic results. Beyond the four mechanisms out-
lined in this paper, various other sources of over-optimism may also affect the reported results. For
instance, one might optimize the evaluation criterion: the sensitivity and specificity may yield other
results than the error rate, especially in case of strongly unequal class sizes. Both prediction measures
are reported in Additional File 2. The applied normalization technique may also affect the results and
yield optimization potential. Another indirect source of over-optimism is related to technical prob-
lems: if an implementation problem occurs with the competing approaches and slightly worsens their
results, researchers often tend to spontaneously accept these inferior results. Conversely, they would
probably obstinately look for the error if such problems occur with their new algorithm.
In our study, the optimistic results obtained with the selected variants of RLDA in the selected
settings turn out to break down when validated based on “fresh” validation data sets. This indicates
that the seemingly favorable results were rather the consequence of intense optimization than the
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illustration of a real superiority of the new method. In a nutshell, let us point out possible reasons
explaining the disappointing performance of the initially promising idea. A general finding of Bickel
and Levina (2004) is that the DLDA highly outperforms the standard LDA in “huge-dimensional”
data situations. Assuming independence between the predictor variables hence does not impair the
classification performance, but rather yields improvement when n ≪ p. This phenomenon has often
been reported in the literature (Dudoit et al., 2002; Domingos and Pazzani, 1997), and it is shown
under broad conditions by Bickel and Levina (2004). Our results confirm this finding in the sense that
incorporating between-genes correlations tends to yield higher error rates with increasing p∗.
Another aspect to be considered is whether the assumptions underlying the new approach do ap-
ply, i.e. whether these assumptions are consistent (at least not evidently inconsistent) with intrinsic
properties of the investigated data. Our own method postulates that genes from the same pathway tend
to be more correlated than genes from different pathways. From the current point of view, however,
the assumption that the between-genes correlation structure is reflected in KEGG pathways and vice
versa is a widespread but dubious assumption on the part of (bio)statisticians. More precisely, this
assumption is dubious for the correlation, which is a measure of linear association. Hence, consider-
ing non-linear association measures might help to uncover the interrelation between KEGG pathways
and the between-genes association structure, and might thus lead to a more adequate modelling of the
latter.
Taken together, these aspects might explain why RLDA based on Σ̂SHIP does not improve the clas-
sification accuracy in terms of prediction error rate. Note, however, that this negative finding could
merely be made through an appropriate validation of the new algorithm. Without proper validation,
we could have obtained a “false positive result”. That said, the proposed shrinkage estimator based on
target G could lead to interesting applications in other contexts like, e.g. canonical correlation analy-
sis. The “disappointing results” reported in this article refer solely to the combination between target
G, KEGG, and linear discriminant analysis – not to the individual components of the combination.
5 Conclusion
In this paper, we demonstrate quantitatively that a combination of various interrelated optimization
mechanisms may yield substantially biased results and over-optimistic conclusions on the superiority
of a new method. Of course, the content of a methodological article should not be reduced to the
effective improvement of accuracy on real data sets. Other aspects of new methods need to be consid-
ered, such as their conceptual simplicity, computational efficiency, interpretability, flexibility, ability
to generalize or fit in a global framework, the absence of strong assumptions or, most importantly, the
originality of the addressed research question. Still we claim that, when improvement of accuracy is
presented as the major contribution, it should be validated using independent data sets that were not
used during the development of the new method.
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